<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33918092</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Links between ALS and NF-&#x3ba;B.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3875</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22083875</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease wherein motor neuron degeneration leads to muscle weakness, progressive paralysis, and death within 3-5 years of diagnosis. Currently, the cause of ALS is unknown but, as with several neurodegenerative diseases, the potential role of neuroinflammation has become an increasingly popular hypothesis in ALS research. Indeed, upregulation of neuroinflammatory factors have been observed in both ALS patients and animal models. One such factor is the inflammatory inducer NF-&#x3ba;B. Besides its connection to inflammation, NF-&#x3ba;B activity can be linked to several genes associated to familial forms of ALS, and many of the environmental risk factors of the disease stimulate NF-&#x3ba;B activation. Collectively, this has led many to hypothesize that NF-&#x3ba;B proteins may play a role in ALS pathogenesis. In this review, we discuss the genetic and environmental connections between NF-&#x3ba;B and ALS, as well as how this pathway may affect different CNS cell types, and finally how this may lead to motor neuron degeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>K&#xe4;llstig</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2282-5690</Identifier><AffiliationInfo><Affiliation>Brain Mind Institute, Ecole Polytechnique F&#xe9;d&#xe9;rale de Lausanne (EPFL), Station 19, 1015 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCabe</LastName><ForeName>Brian D</ForeName><Initials>BD</Initials><Identifier Source="ORCID">0000-0003-1620-0501</Identifier><AffiliationInfo><Affiliation>Brain Mind Institute, Ecole Polytechnique F&#xe9;d&#xe9;rale de Lausanne (EPFL), Station 19, 1015 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Bernard L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0001-5485-8748</Identifier><AffiliationInfo><Affiliation>Brain Mind Institute, Ecole Polytechnique F&#xe9;d&#xe9;rale de Lausanne (EPFL), Station 19, 1015 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>721802</GrantID><Agency>Horizon 2020</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="Y">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004777" MajorTopicYN="N">Environment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009836" MajorTopicYN="N">Oligodendroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">NF-&#x3ba;B</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword></KeywordList><CoiStatement>B.L.S. and B.D.M. are co-founders and shareholders of Avrion Therapeutics.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33918092</ArticleId><ArticleId IdType="pmc">PMC8070122</ArticleId><ArticleId IdType="doi">10.3390/ijms22083875</ArticleId><ArticleId IdType="pii">ijms22083875</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kumar D.R., Aslinia F., Yale S.H., Mazza J.J. Jean-Martin Charcot: The Father of Neurology. Clin. Med. Res. 2011;9:46. doi: 10.3121/cmr.2009.883.</Citation><ArticleIdList><ArticleId IdType="doi">10.3121/cmr.2009.883</ArticleId><ArticleId IdType="pmc">PMC3064755</ArticleId><ArticleId IdType="pubmed">20739583</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L., Shneider N. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Leigh P.N. Amyotrophic Lateral Sclerosis. Orphanet J. Rare Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chi&#xf2; A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E. Eurals Incidence of Amyotrophic Lateral Sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur K.C., Calvo A., Price T.R., Geiger J.T., Chi&#xf2; A., Traynor B.J. Projected Increase in Amyotrophic Lateral Sclerosis from 2015 to 2040. Nat. Commun. 2016;7 doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of Play in Amyotrophic Lateral Sclerosis Genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Suescun J., Chandra S., Schiess M.C. Chapter 13&#x2014;The Role of Neuroinflammation in Neurodegenerative Disorders. In: Actor J.K., Smith K.C., editors. Translational Inflammation. Academic Press; Cambridge, MA, USA: 2019. pp. 241&#x2013;267. Perspectives in Translational Cell Biology.</Citation></Reference><Reference><Citation>Fakhoury M. Microglia and Astrocytes in Alzheimer&#x2019;s Disease: Implications for Therapy. Curr. Neuropharmacol. 2018;16:508&#x2013;518. doi: 10.2174/1570159X15666170720095240.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X15666170720095240</ArticleId><ArticleId IdType="pmc">PMC5997862</ArticleId><ArticleId IdType="pubmed">28730967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponath G., Park C., Pitt D. The Role of Astrocytes in Multiple Sclerosis. Front. Immunol. 2018;9 doi: 10.3389/fimmu.2018.00217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00217</ArticleId><ArticleId IdType="pmc">PMC5826071</ArticleId><ArticleId IdType="pubmed">29515568</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle J., Lindberg R.L.P., Regeniter A., Mehling M., Steck A.J., Kappos L., Czaplinski A. Increased Levels of Inflammatory Chemokines in Amyotrophic Lateral Sclerosis. Eur. J. Neurol. 2009;16:771&#x2013;774. doi: 10.1111/j.1468-1331.2009.02560.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02560.x</ArticleId><ArticleId IdType="pubmed">19236470</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Sikl&#xf3;s L., Appel S.H. The Chemokine MCP-1 and the Dendritic and Myeloid Cells It Attracts Are Increased in the MSOD1 Mouse Model of ALS. Mol. Cell. Neurosci. 2006;31:427&#x2013;437. doi: 10.1016/j.mcn.2005.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.10.016</ArticleId><ArticleId IdType="pubmed">16337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra P.-S., Dhull D.K., Nalini A., Vijayalakshmi K., Sathyaprabha T.N., Alladi P.A., Raju T.R. Astroglia Acquires a Toxic Neuroinflammatory Role in Response to the Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients. J. Neuroinflamm. 2016;13:212. doi: 10.1186/s12974-016-0698-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0698-0</ArticleId><ArticleId IdType="pmc">PMC5006495</ArticleId><ArticleId IdType="pubmed">27578023</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M., G&#xfc;nther R., Akg&#xfc;n K., Hermann A., Ziemssen T. Peripheral Proinflammatory Th1/Th17 Immune Cell Shift Is Linked to Disease Severity in Amyotrophic Lateral Sclerosis. Sci. Rep. 2020;10:5941. doi: 10.1038/s41598-020-62756-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62756-8</ArticleId><ArticleId IdType="pmc">PMC7125229</ArticleId><ArticleId IdType="pubmed">32246039</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X. Motor Neuron Degeneration in Mice That Express a Human Cu, Zn Superoxide Dismutase Mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall E.D., Oostveen J.A., Gurney M.E. Relationship of Microglial and Astrocytic Activation to Disease Onset and Progression in a Transgenic Model of Familial ALS. Glia. 1998;23:249&#x2013;256. doi: 10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">9633809</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu M.E., Kozovska M., Appel S.H. Immune Reactivity in a Mouse Model of Familial ALS Correlates with Disease Progression. Neurology. 2001;57:1282&#x2013;1289. doi: 10.1212/WNL.57.7.1282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.57.7.1282</ArticleId><ArticleId IdType="pubmed">11591849</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia Induce Motor Neuron Death via the Classical NF-&#x39a;B Pathway in Amyotrophic Lateral Sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosio C., Valle C., Casciati A., Iaccarino C., Carr&#xec; M.T. Astroglial Inhibition of NF-&#x39a;B Does Not Ameliorate Disease Onset and Progression in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS) PLoS ONE. 2011;6:e17187. doi: 10.1371/journal.pone.0017187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017187</ArticleId><ArticleId IdType="pmc">PMC3060799</ArticleId><ArticleId IdType="pubmed">21445241</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen R., Baltimore D. Multiple Nuclear Factors Interact with the Immunoglobulin Enhancer Sequences. Cell. 1986;46:705&#x2013;716. doi: 10.1016/0092-8674(86)90346-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(86)90346-6</ArticleId><ArticleId IdType="pubmed">3091258</ArticleId></ArticleIdList></Reference><Reference><Citation>Steward R. Dorsal, an Embryonic Polarity Gene in Drosophila, Is Homologous to the Vertebrate Proto-Oncogene, c-Rel. Science. 1987;238:692&#x2013;694. doi: 10.1126/science.3118464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3118464</ArticleId><ArticleId IdType="pubmed">3118464</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore T.D., Wolenski F.S. NF-&#x39a;B: Where Did It Come from and Why? Immunol. Rev. 2012;246:14&#x2013;35. doi: 10.1111/j.1600-065X.2012.01096.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2012.01096.x</ArticleId><ArticleId IdType="pubmed">22435545</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckinghaus A., Ghosh S. The NF-&#x39a;B Family of Transcription Factors and Its Regulation. Cold Spring Harb. Perspect. Biol. 2009;1 doi: 10.1101/cshperspect.a000034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000034</ArticleId><ArticleId IdType="pmc">PMC2773619</ArticleId><ArticleId IdType="pubmed">20066092</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S.-C. The Non-Canonical NF-&#x39a;B Pathway in Immunity and Inflammation. Nat. Rev. Immunol. 2017;17:545. doi: 10.1038/nri.2017.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.52</ArticleId><ArticleId IdType="pmc">PMC5753586</ArticleId><ArticleId IdType="pubmed">28580957</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih V.F.-S., Tsui R., Caldwell A., Hoffmann A. A Single NF&#x3ba;B System for Both Canonical and Non-Canonical Signaling. Cell Res. 2011;21:86&#x2013;102. doi: 10.1038/cr.2010.161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.161</ArticleId><ArticleId IdType="pmc">PMC3193412</ArticleId><ArticleId IdType="pubmed">21102550</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S.-C. Non-Canonical NF-&#x39a;B Signaling Pathway. Cell Res. 2011;21:71&#x2013;85. doi: 10.1038/cr.2010.177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.177</ArticleId><ArticleId IdType="pmc">PMC3193406</ArticleId><ArticleId IdType="pubmed">21173796</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhang L., Joo D., Sun S.-C. NF-&#x39a;B Signaling in Inflammation. Signal Transduct. Target. Ther. 2017;2:1&#x2013;9. doi: 10.1038/sigtrans.2017.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarnegar B.J., Wang Y., Mahoney D.J., Dempsey P.W., Cheung H.H., He J., Shiba T., Yang X., Yeh W., Mak T.W., et al. Activation of Noncanonical NF-&#x39a;B Requires Coordinated Assembly of a Regulatory Complex of the Adaptors CIAP1, CIAP2, TRAF2, TRAF3 and the Kinase NIK. Nat. Immunol. 2008;9:1371&#x2013;1378. doi: 10.1038/ni.1676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1676</ArticleId><ArticleId IdType="pmc">PMC2676931</ArticleId><ArticleId IdType="pubmed">18997794</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinkenbaugh A.L., Baldwin A.S. The NF-&#x39a;B Pathway and Cancer Stem Cells. Cells. 2016;5:16. doi: 10.3390/cells5020016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells5020016</ArticleId><ArticleId IdType="pmc">PMC4931665</ArticleId><ArticleId IdType="pubmed">27058560</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Lenardo M.J., Baltimore D. 30 Years of NF-&#x39a;B: A Blossoming of Relevance to Human Pathobiology. Cell. 2017;168:37&#x2013;57. doi: 10.1016/j.cell.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5268070</ArticleId><ArticleId IdType="pubmed">28086098</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.-C., Lidov H.G.W., Hasselgren P.-O., Frontera W.R., Lee J., Glass D.J., et al. IKKbeta/NF-KappaB Activation Causes Severe Muscle Wasting in Mice. Cell. 2004;119:285&#x2013;298. doi: 10.1016/j.cell.2004.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.09.027</ArticleId><ArticleId IdType="pubmed">15479644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Fu X.-Q., Lei W.-L., Wang T., Sheng A.-L., Luo Z.-G. Nuclear Factor &#x39a;B Controls Acetylcholine Receptor Clustering at the Neuromuscular Junction. J. Neurosci. 2010;30:11104&#x2013;11113. doi: 10.1523/JNEUROSCI.2118-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2118-10.2010</ArticleId><ArticleId IdType="pmc">PMC6633475</ArticleId><ArticleId IdType="pubmed">20720118</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A., Za&#xef;di S., Iltis C., Ribon M., Berriat F., Schiaffino L., Jolly A., de la Grange P., Mallat M., Bohl D., et al. Modifying Macrophages at the Periphery Has the Capacity to Change Microglial Reactivity and to Extend ALS Survival. Nat. Neurosci. 2020;23:1339&#x2013;1351. doi: 10.1038/s41593-020-00718-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00718-z</ArticleId><ArticleId IdType="pubmed">33077946</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Cheng X., Zhong S., Zhang X., Liu C., Liu F., Zhao C. Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis. Front. Neurosci. 2020;14 doi: 10.3389/fnins.2020.00575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00575</ArticleId><ArticleId IdType="pmc">PMC7308438</ArticleId><ArticleId IdType="pubmed">32612503</ArticleId></ArticleIdList></Reference><Reference><Citation>Meffert M.K., Chang J.M., Wiltgen B.J., Fanselow M.S., Baltimore D. NF-Kappa B Functions in Synaptic Signaling and Behavior. Nat. Neurosci. 2003;6:1072&#x2013;1078. doi: 10.1038/nn1110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1110</ArticleId><ArticleId IdType="pubmed">12947408</ArticleId></ArticleIdList></Reference><Reference><Citation>Meffert M.K., Baltimore D. Physiological Functions for Brain NF-KappaB. Trends Neurosci. 2005;28:37&#x2013;43. doi: 10.1016/j.tins.2004.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2004.11.002</ArticleId><ArticleId IdType="pubmed">15626495</ArticleId></ArticleIdList></Reference><Reference><Citation>Albensi B.C., Mattson M.P. Evidence for the Involvement of TNF and NF-KappaB in Hippocampal Synaptic Plasticity. Synapse. 2000;35:151&#x2013;159. doi: 10.1002/(SICI)1098-2396(200002)35:2&lt;151::AID-SYN8&gt;3.0.CO;2-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-2396(200002)35:2&lt;151::AID-SYN8&gt;3.0.CO;2-P</ArticleId><ArticleId IdType="pubmed">10611641</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuman E.M., Madison D.V. Nitric Oxide and Synaptic Function. Annu. Rev. Neurosci. 1994;17:153&#x2013;183. doi: 10.1146/annurev.ne.17.030194.001101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.ne.17.030194.001101</ArticleId><ArticleId IdType="pubmed">7516125</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H.P., Van Broeckhoven C., van der Zee J. ALS Genes in the Genomic Era and Their Implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V., Dutta K., Phaneuf D., Sobue G., Julien J.-P. Ubiquilin-2 Drives NF-&#x39a;B Activity and Cytosolic TDP-43 Aggregation in Neuronal Cells. Mol. Brain. 2015;8:71. doi: 10.1186/s13041-015-0162-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0162-6</ArticleId><ArticleId IdType="pmc">PMC4628361</ArticleId><ArticleId IdType="pubmed">26521126</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolland P., Madjd Z., Durrant L., Ellis I.O., Layfield R., Spendlove I. The Ubiquitin-Binding Protein P62 Is Expressed in Breast Cancers Showing Features of Aggressive Disease. Endocr. Relat. Cancer. 2007;14:73&#x2013;80. doi: 10.1677/erc.1.01312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/erc.1.01312</ArticleId><ArticleId IdType="pubmed">17395976</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Orrell R.W. Pathogenesis of Amyotrophic Lateral Sclerosis. Br. Med. Bull. 2016;119:87&#x2013;98. doi: 10.1093/bmb/ldw026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Vercruysse T., Boeynaems S., Sicart A., Van Damme P., Daelemans D., Van Den Bosch L. C9orf72-Generated Poly-GR and Poly-PR Do Not Directly Interfere with Nucleocytoplasmic Transport. Sci. Rep. 2019;9:15728. doi: 10.1038/s41598-019-52035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52035-6</ArticleId><ArticleId IdType="pmc">PMC6823349</ArticleId><ArticleId IdType="pubmed">31673013</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennion Callister J., Pickering-Brown S.M. Pathogenesis/Genetics of Frontotemporal Dementia and How It Relates to ALS. Pt BExp. Neurol. 2014;262:84&#x2013;90. doi: 10.1016/j.expneurol.2014.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.06.001</ArticleId><ArticleId IdType="pmc">PMC4221591</ArticleId><ArticleId IdType="pubmed">24915640</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-Mediated ALS and FTD: Multiple Pathways to Disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Green K.M., Linsalata A.E., Todd P.K. RAN Translation&#x2014;What Makes It Run? Brain Res. 2016;1647:30&#x2013;42. doi: 10.1016/j.brainres.2016.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.003</ArticleId><ArticleId IdType="pmc">PMC5003667</ArticleId><ArticleId IdType="pubmed">27060770</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Suzuki N., Wang J.-Y., Moccia R., Mordes D.A., Stewart M.H., Suzuki-Uematsu S., Ghosh S., Singh A., Merkle F.T., et al. Loss-of-Function Mutations in the C9ORF72 Mouse Ortholog Cause Fatal Autoimmune Disease. Sci. Transl. Med. 2016;8:347ra93. doi: 10.1126/scitranslmed.aaf6038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A., Decman V., White D., Ramos M., Ikiz B., Lee H.-C., Siao C.-J., Brydges S., LaRosa E., Bai Y., et al. C9orf72 Ablation Causes Immune Dysregulation Characterized by Leukocyte Expansion, Autoantibody Production, and Glomerulonephropathy in Mice. Sci. Rep. 2016;6:23204. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Y&#xe1;&#xf1;ez A., Lall D., Wolf A.J., Muhammad A.K.M.G., Ho R., Carmona S., Vit J.P., Zarrow J., et al. C9orf72 Is Required for Proper Macrophage and Microglial Function in Mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., O&#x2019;Rourke J.G., Y&#xe1;&#xf1;ez A., Markman J.L., Ho R., Wang X., Chen S., Lall D., Jin M., Muhammad A.K.M.G., et al. C9orf72 in Myeloid Cells Suppresses STING-Induced Inflammation. Nature. 2020;585:96&#x2013;101. doi: 10.1038/s41586-020-2625-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2625-x</ArticleId><ArticleId IdType="pmc">PMC7484469</ArticleId><ArticleId IdType="pubmed">32814898</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Wells M.F., Limone F., Couto A., Smith K.S., Keaney J., Gillet G., van Gastel N., Wang J.-Y., Pietilainen O., et al. C9orf72 Suppresses Systemic and Neural Inflammation Induced by Gut Bacteria. Nature. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomin V., Richard P., Hoque M., Li C., Gu Z., Fissore-O&#x2019;Leary M., Tian B., Prives C., Manley J.L. The C9ORF72 Gene, Implicated in ALS/FTD, Encodes a Protein That Functions in Control of Endothelin and Glutamate Signaling. Mol. Cell. Biol. 2018 doi: 10.1128/MCB.00155-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00155-18</ArticleId><ArticleId IdType="pmc">PMC6206455</ArticleId><ArticleId IdType="pubmed">30150298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur S.J., McKeown S.R., Rashid S. Mutant SOD1 Mediated Pathogenesis of Amyotrophic Lateral Sclerosis. Gene. 2016;577:109&#x2013;118. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M., Valentine J.S. Aggregation of Copper-Zinc Superoxide Dismutase in Familial and Sporadic ALS. Antioxid. Redox Signal. 2009;11:1603&#x2013;1614. doi: 10.1089/ars.2009.2536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2536</ArticleId><ArticleId IdType="pmc">PMC2842589</ArticleId><ArticleId IdType="pubmed">19271992</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochat C., Bernard-Marissal N., Pradervand S., Perrin F.E., Raoul C., Aebischer P., Schneider B.L. Expression of a MiRNA Targeting Mutated SOD1 in Astrocytes Induces Motoneuron Plasticity and Improves Neuromuscular Function in ALS Mice. bioRxiv. 2021 doi: 10.1101/2021.01.08.425706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.08.425706</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-Type Microglia Extend Survival in PU.1 Knockout Mice with Familial Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2006;103:16021&#x2013;16026. doi: 10.1073/pnas.0607423103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan K.A., Weigel M.K., Adler D.I., Couthouis J., Liddelow S.A., Gitler A.D., Barres B.A. Knockout of Reactive Astrocyte Activating Factors Slows Disease Progression in an ALS Mouse Model. Nat. Commun. 2020;11:3753. doi: 10.1038/s41467-020-17514-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17514-9</ArticleId><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Nivon M., Fort L., Muller P., Richet E., Simon S., Guey B., Fournier M., Arrigo A.-P., Hetz C., Atkin J.D., et al. NF&#x3ba;B Is a Central Regulator of Protein Quality Control in Response to Protein Aggregation Stresses via Autophagy Modulation. Mol. Biol. Cell. 2016;27:1712&#x2013;1727. doi: 10.1091/mbc.e15-12-0835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e15-12-0835</ArticleId><ArticleId IdType="pmc">PMC4884063</ArticleId><ArticleId IdType="pubmed">27075172</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Lautenschl&#xe4;ger J., Weidemann L., Ruhmer J., Witte O.W., Grosskreutz J. Endoplasmic Reticulum Stress Is Accompanied by Activation of NF-&#x39a;B in Amyotrophic Lateral Sclerosis. J. Neuroimmunol. 2014;270:29&#x2013;36. doi: 10.1016/j.jneuroim.2014.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2014.03.005</ArticleId><ArticleId IdType="pubmed">24666819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H., Funk C., Abou-Ajram C., Hutten S., Funk E.B.E., Kehlenbach R.H., Bailer S.M., Dormann D. Nuclear Egress of TDP-43 and FUS Occurs Independently of Exportin-1/CRM1. Sci. Rep. 2018;8 doi: 10.1038/s41598-018-25007-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25007-5</ArticleId><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y., Kuta R., Grasmuck C., Prat A., Durham H.D., Vande Velde C. TDP-43 Regulation of Stress Granule Dynamics in Neurodegenerative Disease-Relevant Cell Types. Sci. Rep. 2018;8:7551. doi: 10.1038/s41598-018-25767-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25767-0</ArticleId><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V., Phaneuf D., Dupr&#xe9; N., Petri S., Strong M., Kriz J., Julien J.-P. Deregulation of TDP-43 in Amyotrophic Lateral Sclerosis Triggers Nuclear Factor &#x39a;B&#x2013;Mediated Pathogenic Pathways. J. Exp. Med. 2011;208:2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.-H., Davidson S., Harapas C.R., Hilton J.B., Mlodzianoski M.J., Laohamonthonkul P., Louis C., Low R.R.J., Moecking J., De Nardo D., et al. TDP-43 Triggers Mitochondrial DNA Release via MPTP to Activate CGAS/STING in ALS. Cell. 2020;183:636&#x2013;649.e18. doi: 10.1016/j.cell.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara J.H., Gautam M., Kocak N., Xie E.F., Mao Q., Bigio E.H., &#xd6;zdinler P.H. MCP1-CCR2 and Neuroinflammation in the ALS Motor Cortex with TDP-43 Pathology. J. Neuroinflamm. 2019;16:196. doi: 10.1186/s12974-019-1589-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1589-y</ArticleId><ArticleId IdType="pmc">PMC6822373</ArticleId><ArticleId IdType="pubmed">31666087</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim S., Kang H.-Y., Lim H.R., Kwon Y., Jo M., Jeon Y.-M., Kim S.R., Kim K., Ha C.M., et al. The Overexpression of TDP-43 in Astrocytes Causes Neurodegeneration via a PTP1B-Mediated Inflammatory Response. J. Neuroinflamm. 2020;17 doi: 10.1186/s12974-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamudio F., Loon A.R., Smeltzer S., Benyamine K., Navalpur Shanmugam N.K., Stewart N.J.F., Lee D.C., Nash K., Selenica M.-L.B. TDP-43 Mediated Blood-Brain Barrier Permeability and Leukocyte Infiltration Promote Neurodegeneration in a Low-Grade Systemic Inflammation Mouse Model. J. Neuroinflamm. 2020;17:283. doi: 10.1186/s12974-020-01952-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01952-9</ArticleId><ArticleId IdType="pmc">PMC7519496</ArticleId><ArticleId IdType="pubmed">32979923</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia A.S., Patel P., Dutta K., Julien J.-P. Inflammation Induces TDP-43 Mislocalization and Aggregation. PLoS ONE. 2015;10 doi: 10.1371/journal.pone.0140248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140248</ArticleId><ArticleId IdType="pmc">PMC4596857</ArticleId><ArticleId IdType="pubmed">26444430</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Scotter E.L., Nishimura A.L., Troakes C., Mitchell J.C., Kathe C., Urwin H., Manser C., Miller C.C., Hortob&#xe1;gyi T., et al. ALS Mutant FUS Disrupts Nuclear Localization and Sequesters Wild-Type FUS within Cytoplasmic Stress Granules. Hum. Mol. Genet. 2013;22:2676&#x2013;2688. doi: 10.1093/hmg/ddt117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt117</ArticleId><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya T., Maragkakis M. Amyotrophic Lateral Sclerosis Associated FUS Mutation Shortens Mitochondria and Induces Neurotoxicity. Sci. Rep. 2018;8:15575. doi: 10.1038/s41598-018-33964-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33964-0</ArticleId><ArticleId IdType="pmc">PMC6197261</ArticleId><ArticleId IdType="pubmed">30349096</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J., Tadokoro T., Baughn M.W., Myers B., McAlonis-Downes M., Chillon-Marinas C., Asiaban J.N., Artates J., Bui A.T., Vetto A.P., et al. ALS/FTD-Linked Mutation in FUS Suppresses Intra-Axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS. Neuron. 2018;100:816&#x2013;830.e7. doi: 10.1016/j.neuron.2018.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.-W., Brent J.R., Tomlinson A., Shneider N.A., McCabe B.D. The ALS-Associated Proteins FUS and TDP-43 Function Together to Affect Drosophila Locomotion and Life Span. J. Clin. Investig. 2011;121:4118&#x2013;4126. doi: 10.1172/JCI57883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57883</ArticleId><ArticleId IdType="pmc">PMC3195475</ArticleId><ArticleId IdType="pubmed">21881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Uranishi H., Tetsuka T., Yamashita M., Asamitsu K., Shimizu M., Itoh M., Okamoto T. Involvement of the Pro-Oncoprotein TLS (Translocated in Liposarcoma) in Nuclear Factor-&#x39a;B P65-Mediated Transcription as a Coactivator. J. Biol. Chem. 2001;276:13395&#x2013;13401. doi: 10.1074/jbc.M011176200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M011176200</ArticleId><ArticleId IdType="pubmed">11278855</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova T.A., An H., Skelt L., Tregoning J.S., Humphreys I.R., Buchman V.L. Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis. Cell Rep. 2019;29:4496&#x2013;4508.e4. doi: 10.1016/j.celrep.2019.11.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.094</ArticleId><ArticleId IdType="pmc">PMC6941233</ArticleId><ArticleId IdType="pubmed">31875556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat M.A., Onori A., Toselli C., Stronati E., Morlando M., Bozzoni I., Monni E., Kokaia Z., Lupo G., Minghetti L., et al. Increased FUS Levels in Astrocytes Leads to Astrocyte and Microglia Activation and Neuronal Death. Sci. Rep. 2019;9:4572. doi: 10.1038/s41598-019-41040-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41040-4</ArticleId><ArticleId IdType="pmc">PMC6418113</ArticleId><ArticleId IdType="pubmed">30872738</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovinovic A., Cimbro R., Ljutic T., Kriz J., Rogelj B., Munitic I. Optineurin in Amyotrophic Lateral Sclerosis: Multifunctional Adaptor Protein at the Crossroads of Different Neuroprotective Mechanisms. Prog. Neurobiol. 2017;154:1&#x2013;20. doi: 10.1016/j.pneurobio.2017.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2017.04.005</ArticleId><ArticleId IdType="pubmed">28456633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan T.A., Tumbarello D.A. Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy. Front. Immunol. 2018;9:1024. doi: 10.3389/fimmu.2018.01024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01024</ArticleId><ArticleId IdType="pmc">PMC5962687</ArticleId><ArticleId IdType="pubmed">29867991</ArticleId></ArticleIdList></Reference><Reference><Citation>Slowicka K., van Loo G. Optineurin Functions for Optimal Immunity. Front. Immunol. 2018;9 doi: 10.3389/fimmu.2018.00769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00769</ArticleId><ArticleId IdType="pmc">PMC5902560</ArticleId><ArticleId IdType="pubmed">29692786</ArticleId></ArticleIdList></Reference><Reference><Citation>Akizuki M., Yamashita H., Uemura K., Maruyama H., Kawakami H., Ito H., Takahashi R. Optineurin Suppression Causes Neuronal Cell Death via NF-&#x39a;B Pathway. J. Neurochem. 2013;126:699&#x2013;704. doi: 10.1111/jnc.12326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12326</ArticleId><ArticleId IdType="pubmed">23721573</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamada M., Izumi Y., Ayaki T., Nakamura M., Kagawa S., Kudo E., Sako W., Maruyama H., Nishida Y., Kawakami H., et al. Clinicopathologic Features of Autosomal Recessive Amyotrophic Lateral Sclerosis Associated with Optineurin Mutation. Neuropathology. 2014;34:64&#x2013;70. doi: 10.1111/neup.12051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12051</ArticleId><ArticleId IdType="pubmed">23889540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako W., Ito H., Yoshida M., Koizumi H., Kamada M., Fujita K., Hashizume Y., Izumi Y., Kaji R. Nuclear Factor &#x3ba; B Expression in Patients with Sporadic Amyotrophic Lateral Sclerosis and Hereditary Amyotrophic Lateral Sclerosis with Optineurin Mutations. Clin. Neuropathol. 2012;31:418&#x2013;423. doi: 10.5414/NP300493.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300493</ArticleId><ArticleId IdType="pubmed">22762947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y., Ofengeim D., Najafov A., Das S., Saberi S., Li Y., Hitomi J., Zhu H., Chen H., Mayo L., et al. RIPK1 Mediates Axonal Degeneration by Promoting Inflammation and Necroptosis in ALS. Science. 2016;353:603&#x2013;608. doi: 10.1126/science.aaf6803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>De Diego R.P., Rodr&#xed;guez-Gallego C. Chapter 34&#x2014;Other TLR Pathway Defects. In: Sullivan K.E., Stiehm E.R., editors. Stiehm&#x2019;s Immune Deficiencies. Academic Press; Amsterdam, The Netherlands: 2014. pp. 687&#x2013;710.</Citation></Reference><Reference><Citation>Sweeney S.E., Mo L., Firestein G.S. Antiviral Gene Expression in Rheumatoid Arthritis: Role of IKK&#x3f5; and Interferon Regulatory Factor 3. Arthritis Rheum. 2007;56:743&#x2013;752. doi: 10.1002/art.22421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22421</ArticleId><ArticleId IdType="pubmed">17328045</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomerantz J.L., Baltimore D. NF-KappaB Activation by a Signaling Complex Containing TRAF2, TANK and TBK1, a Novel IKK-Related Kinase. EMBO J. 1999;18:6694&#x2013;6704. doi: 10.1093/emboj/18.23.6694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.23.6694</ArticleId><ArticleId IdType="pmc">PMC1171732</ArticleId><ArticleId IdType="pubmed">10581243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying H., Yue B.Y.J.T. Chapter five&#x2014;Cellular and Molecular Biology of Optineurin. In: Jeon K.W., editor. International Review of Cell and Molecular Biology. Volume 294. Academic Press; Cambridge, MA, USA: 2012. pp. 223&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3673586</ArticleId><ArticleId IdType="pubmed">22364875</ArticleId></ArticleIdList></Reference><Reference><Citation>De Majo M., Topp S.D., Smith B.N., Nishimura A.L., Chen H.-J., Gkazi A.S., Miller J., Wong C.H., Vance C., Baas F., et al. ALS-Associated Missense and Nonsense TBK1 Mutations Can Both Cause Loss of Kinase Function. Neurobiol. Aging. 2018;71:266.e1&#x2013;266.e10. doi: 10.1016/j.neurobiolaging.2018.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.015</ArticleId><ArticleId IdType="pmc">PMC6983933</ArticleId><ArticleId IdType="pubmed">30033073</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V., Kaunga E., Ye J., Canzio D., O&#x2019;Keeffe S., Rudnick N.D., Guarnieri P., Lutz C.M., Maniatis T. The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice. Neuron. 2020;106:789&#x2013;805.e5. doi: 10.1016/j.neuron.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.03.005</ArticleId><ArticleId IdType="pubmed">32220666</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Sieverding K., Bruno C., L&#xfc;ningschr&#xf6;r P., Buck E., Mungwa S., Fischer L., Brockmann S.J., Ulmer J., Bliederh&#xe4;user C., et al. Heterozygous Tbk1 Loss Has Opposing Effects in Early and Late Stages of ALS in Mice. J. Exp. Med. 2019;216:267&#x2013;278. doi: 10.1084/jem.20180729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180729</ArticleId><ArticleId IdType="pmc">PMC6363427</ArticleId><ArticleId IdType="pubmed">30635357</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A., Logroscino G., Hern&#xe1;n M.A. Smoking and the Risk of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. J. Neurol. Neurosurg. Psychiatry. 2010;81:1249&#x2013;1252. doi: 10.1136/jnnp.2009.180232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.180232</ArticleId><ArticleId IdType="pubmed">20639382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., O&#x2019;Reilly E., Weisskopf M., Logroscino G., McCullough M., Thun M., Schatzkin A., Kolonel L., Ascherio A. Smoking and Risk of Amyotrophic Lateral Sclerosis: A Pooled Analysis of 5 Prospective Cohorts. Arch. Neurol. 2011;68:207&#x2013;213. doi: 10.1001/archneurol.2010.367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.367</ArticleId><ArticleId IdType="pmc">PMC3319086</ArticleId><ArticleId IdType="pubmed">21320987</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen M., van Doormaal P.T.C., Visser A.E., Huisman M.H.B., Roozekrans M.H.J., de Jong S.W., van der Kooi A.J., de Visser M., Voermans N.C., Veldink J.H., et al. Prior Medical Conditions and the Risk of Amyotrophic Lateral Sclerosis. J. Neurol. 2014;261:1949&#x2013;1956. doi: 10.1007/s00415-014-7445-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7445-1</ArticleId><ArticleId IdType="pubmed">25059395</ArticleId></ArticleIdList></Reference><Reference><Citation>McCambridge M., Stinson M.J. Advances in Chronic Traumatic Encephalopathy. JAAPA Off. J. Am. Acad. Physician Assist. 2020;33:39&#x2013;42. doi: 10.1097/01.JAA.0000654008.48462.01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.JAA.0000654008.48462.01</ArticleId><ArticleId IdType="pubmed">32217906</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Horton D.K., Mitsumoto H. Potential Environmental Factors in Amyotrophic Lateral Sclerosis. Neurol. Clin. 2015;33:877&#x2013;888. doi: 10.1016/j.ncl.2015.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.009</ArticleId><ArticleId IdType="pmc">PMC4646848</ArticleId><ArticleId IdType="pubmed">26515627</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman M.H.B., Seelen M., de Jong S.W., Dorresteijn K.R.I.S., van Doormaal P.T.C., van der Kooi A.J., de Visser M., Schelhaas H.J., van den Berg L.H., Veldink J.H. Lifetime Physical Activity and the Risk of Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry. 2013;84:976&#x2013;981. doi: 10.1136/jnnp-2012-304724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304724</ArticleId><ArticleId IdType="pubmed">23418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Kwee L.C., Allen K.D., Umbach D.M., Ye W., Watson M., Keller J., Oddone E.Z., Sandler D.P., Schmidt S., et al. Association between Blood Lead and the Risk of Amyotrophic Lateral Sclerosis. Am. J. Epidemiol. 2010;171:1126&#x2013;1133. doi: 10.1093/aje/kwq063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq063</ArticleId><ArticleId IdType="pmc">PMC2877471</ArticleId><ArticleId IdType="pubmed">20406759</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-Z., Wang Y.-X., Jiang C.-L. Inflammation: The Common Pathway of Stress-Related Diseases. Front. Hum. Neurosci. 2017;11 doi: 10.3389/fnhum.2017.00316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2017.00316</ArticleId><ArticleId IdType="pmc">PMC5476783</ArticleId><ArticleId IdType="pubmed">28676747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzoni V., Pansarasa O., Diamanti L., Nosari G., Cereda C., Ceroni M. Amyotrophic Lateral Sclerosis and Environmental Factors. Funct. Neurol. 2016;31:7&#x2013;19. doi: 10.11138/FNeur/2016.31.1.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.11138/FNeur/2016.31.1.007</ArticleId><ArticleId IdType="pmc">PMC4819821</ArticleId><ArticleId IdType="pubmed">27027889</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks C.N., Lein P.J. A Review of Experimental Evidence Linking Neurotoxic Organophosphorus Compounds and Inflammation. Neurotoxicology. 2012;33:575&#x2013;584. doi: 10.1016/j.neuro.2012.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2012.02.002</ArticleId><ArticleId IdType="pmc">PMC3358519</ArticleId><ArticleId IdType="pubmed">22342984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A., Weisskopf M.G., O&#x2019;reilly E.J., Jacobs E.J., McCullough M.L., Calle E.E., Cudkowicz M., Thun M.J. Vitamin E Intake and Risk of Amyotrophic Lateral Sclerosis. Ann. Neurol. 2005;57:104&#x2013;110. doi: 10.1002/ana.20316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20316</ArticleId><ArticleId IdType="pubmed">15529299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Zhang X., Li J.J. The Role of NF-&#x39a;B in the Regulation of Cell Stress Responses. Int. Immunopharmacol. 2002;2:1509&#x2013;1520. doi: 10.1016/S1567-5769(02)00058-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1567-5769(02)00058-9</ArticleId><ArticleId IdType="pubmed">12433052</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana F., Foti M., Virtuoso A., Gaglio D., Aprea F., Latronico T., Rossano R., Riccio P., Papa M., Alberghina L., et al.  Differential Modulation of NF-&#x39a;B in Neurons and Astrocytes Underlies Neuroprotection and Antigliosis Activity of Natural Antioxidant Molecules.  [(accessed on 3 February 2021)]; Available online:  https://www.hindawi.com/journals/omcl/2019/8056904/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6710787</ArticleId><ArticleId IdType="pubmed">31485299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratsovnik E., Bromberg Y., Sperling O., Zoref-Shani E. Oxidative Stress Activates Transcription Factor NF-KB-Mediated Protective Signaling in Primary Rat Neuronal Cultures. J. Mol. Neurosci. 2005;26:27&#x2013;32. doi: 10.1385/JMN:26:1:027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/JMN:26:1:027</ArticleId><ArticleId IdType="pubmed">15968083</ArticleId></ArticleIdList></Reference><Reference><Citation>Delzor A., Couratier P., Boum&#xe9;di&#xe8;ne F., Nicol M., Druet-Cabanac M., Paraf F., M&#xe9;jean A., Ploux O., Leleu J.-P., Brient L., et al. Searching for a Link between the L-BMAA Neurotoxin and Amyotrophic Lateral Sclerosis: A Study Protocol of the French BMAALS Programme. BMJ Open. 2014;4:e005528. doi: 10.1136/bmjopen-2014-005528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005528</ArticleId><ArticleId IdType="pmc">PMC4156816</ArticleId><ArticleId IdType="pubmed">25180055</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva D.F., Candeias E., Esteves A.R., Magalh&#xe3;es J.D., Ferreira I.L., Nunes-Costa D., Rego A.C., Empadinhas N., Cardoso S.M. Microbial BMAA Elicits Mitochondrial Dysfunction, Innate Immunity Activation, and Alzheimer&#x2019;s Disease Features in Cortical Neurons. J. Neuroinflamm. 2020;17:332. doi: 10.1186/s12974-020-02004-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-02004-y</ArticleId><ArticleId IdType="pmc">PMC7643281</ArticleId><ArticleId IdType="pubmed">33153477</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso R., Pisa D., Carrasco L. Searching for Bacteria in Neural Tissue From Amyotrophic Lateral Sclerosis. Front. Neurosci. 2019;13 doi: 10.3389/fnins.2019.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00171</ArticleId><ArticleId IdType="pmc">PMC6399391</ArticleId><ArticleId IdType="pubmed">30863279</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolson G.L., Nasralla M.Y., Haier J., Pomfret J. High Frequency of Systemic Mycoplasmal Infections in Gulf War Veterans and Civilians with Amyotrophic Lateral Sclerosis (ALS) J. Clin. Neurosci. 2002;9:525&#x2013;529. doi: 10.1054/jocn.2001.1075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/jocn.2001.1075</ArticleId><ArticleId IdType="pubmed">12383408</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nsel Y., Ackerl M., Stanek G. ALS-like sequelae in chronic neuroborreliosis. Wien. Med. Wochenschr. 1995;145:186&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">7610670</ArticleId></ArticleIdList></Reference><Reference><Citation>Halperin J.J., Kaplan G.P., Brazinsky S., Tsai T.F., Cheng T., Ironside A., Wu P., Delfiner J., Golightly M., Brown R.H. Immunologic Reactivity against Borrelia Burgdorferi in Patients with Motor Neuron Disease. Arch. Neurol. 1990;47:586&#x2013;594. doi: 10.1001/archneur.1990.00530050110021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1990.00530050110021</ArticleId><ArticleId IdType="pubmed">2334308</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen H.B. Alzheimer&#x2019;s Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-&#x3b2; with Regard to Potential Treatment and Prevention. J. Alzheimers Dis. 2016;53:1271&#x2013;1276. doi: 10.3233/JAD-160388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160388</ArticleId><ArticleId IdType="pmc">PMC5008232</ArticleId><ArticleId IdType="pubmed">27372648</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolson G.L. Chronic Bacterial and Viral Infections in Neurodegenerative and Neurobehavioral Diseases. Lab. Med. 2008;39:291&#x2013;299. doi: 10.1309/96M3BWYP42L11BFU.</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/96M3BWYP42L11BFU</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashyap S., Sarkar M. Mycoplasma Pneumonia: Clinical Features and Management. Lung India Off. Organ Indian Chest Soc. 2010;27:75&#x2013;85. doi: 10.4103/0970-2113.63611.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0970-2113.63611</ArticleId><ArticleId IdType="pmc">PMC2893430</ArticleId><ArticleId IdType="pubmed">20616940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebnet K., Brown K.D., Siebenlist U.K., Simon M.M., Shaw S. Borrelia Burgdorferi Activates Nuclear Factor-Kappa B and Is a Potent Inducer of Chemokine and Adhesion Molecule Gene Expression in Endothelial Cells and Fibroblasts. J. Immunol. 1997;158:3285&#x2013;3292.</Citation><ArticleIdList><ArticleId IdType="pubmed">9120285</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown G.C. The Endotoxin Hypothesis of Neurodegeneration. J. Neuroinflamm. 2019;16:180. doi: 10.1186/s12974-019-1564-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1564-7</ArticleId><ArticleId IdType="pmc">PMC6744684</ArticleId><ArticleId IdType="pubmed">31519175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Miller R.G., Gascon R., Champion S., Katz J., Lancero M., Narvaez A., Honrada R., Ruvalcaba D., McGrath M.S. Circulating Endotoxin and Systemic Immune Activation in Sporadic Amyotrophic Lateral Sclerosis (SALS) J. Neuroimmunol. 2009;206:121&#x2013;124. doi: 10.1016/j.jneuroim.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2008.09.017</ArticleId><ArticleId IdType="pmc">PMC2995297</ArticleId><ArticleId IdType="pubmed">19013651</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.-S., Knapp D.J., Crews F.T. Systemic LPS Causes Chronic Neuroinflammation and Progressive Neurodegeneration. Glia. 2007;55:453&#x2013;462. doi: 10.1002/glia.20467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20467</ArticleId><ArticleId IdType="pmc">PMC2871685</ArticleId><ArticleId IdType="pubmed">17203472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakaria R., Wan Yaacob W.M., Othman Z., Long I., Ahmad A.H., Al-Rahbi B. Lipopolysaccharide-Induced Memory Impairment in Rats: A Model of Alzheimer&#x2019;s Disease. Physiol. Res. 2017;66:553&#x2013;565. doi: 10.33549/physiolres.933480.</Citation><ArticleIdList><ArticleId IdType="doi">10.33549/physiolres.933480</ArticleId><ArticleId IdType="pubmed">28406691</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris M.C., Gilliam E.A., Li L. Innate Immune Programing by Endotoxin and Its Pathological Consequences. Front. Immunol. 2015;5 doi: 10.3389/fimmu.2014.00680.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00680</ArticleId><ArticleId IdType="pmc">PMC4285116</ArticleId><ArticleId IdType="pubmed">25610440</ArticleId></ArticleIdList></Reference><Reference><Citation>Coque E., Salsac C., Espinosa-Carrasco G., Varga B., Degauque N., Cadoux M., Crab&#xe9; R., Virenque A., Soulard C., Fierle J.K., et al. Cytotoxic CD8+ T Lymphocytes Expressing ALS-Causing SOD1 Mutant Selectively Trigger Death of Spinal Motoneurons. Proc. Natl. Acad. Sci. USA. 2019;116:2312&#x2013;2317. doi: 10.1073/pnas.1815961116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1815961116</ArticleId><ArticleId IdType="pmc">PMC6369778</ArticleId><ArticleId IdType="pubmed">30674678</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto K., Nakajima K. Role of the Immune System in the Development of the Central Nervous System. Front. Neurosci. 2019;13 doi: 10.3389/fnins.2019.00916.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00916</ArticleId><ArticleId IdType="pmc">PMC6735264</ArticleId><ArticleId IdType="pubmed">31551681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassed C.A., Herkenham M. NF-&#x39a;B P50-Deficient Mice Show Reduced Anxiety-like Behaviors in Tests of Exploratory Drive and Anxiety. Behav. Brain Res. 2004;154:577&#x2013;584. doi: 10.1016/j.bbr.2004.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2004.03.026</ArticleId><ArticleId IdType="pubmed">15313047</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikawa K., Odero G.L., Platt E., Neuendorff M., Hatherell A., Bernstein M.J., Albensi B.C. NF-&#x39a;B P50 Subunit Knockout Impairs Late LTP and Alters Long Term Memory in the Mouse Hippocampus. BMC Neurosci. 2012;13:45. doi: 10.1186/1471-2202-13-45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-13-45</ArticleId><ArticleId IdType="pmc">PMC3394209</ArticleId><ArticleId IdType="pubmed">22553912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H.J., Hernandez C.M., Levenson J.M., Lubin F.D., Liou H.-C., Sweatt J.D. C-Rel, an NF-&#x39a;B Family Transcription Factor, Is Required for Hippocampal Long-Term Synaptic Plasticity and Memory Formation. Learn. Mem. 2008;15:539&#x2013;549. doi: 10.1101/lm.866408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/lm.866408</ArticleId><ArticleId IdType="pmc">PMC2505322</ArticleId><ArticleId IdType="pubmed">18626097</ArticleId></ArticleIdList></Reference><Reference><Citation>Boersma M.C.H., Dresselhaus E.C., Biase L.M.D., Mihalas A.B., Bergles D.E., Meffert M.K. A Requirement for Nuclear Factor-&#x39a;B in Developmental and Plasticity-Associated Synaptogenesis. J. Neurosci. 2011;31:5414&#x2013;5425. doi: 10.1523/JNEUROSCI.2456-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2456-10.2011</ArticleId><ArticleId IdType="pmc">PMC3113725</ArticleId><ArticleId IdType="pubmed">21471377</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrini L., Molteni A., Wirth T., Kistler B., Blasi F. Glutamate-Dependent Activation of NF-&#x39a;B During Mouse Cerebellum Development. J. Neurosci. 1997;17:6057&#x2013;6063. doi: 10.1523/JNEUROSCI.17-16-06057.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.17-16-06057.1997</ArticleId><ArticleId IdType="pmc">PMC6568342</ArticleId><ArticleId IdType="pubmed">9236217</ArticleId></ArticleIdList></Reference><Reference><Citation>Dresselhaus E.C., Meffert M.K. Cellular Specificity of NF-&#x39a;B Function in the Nervous System. Front. Immunol. 2019;10 doi: 10.3389/fimmu.2019.01043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01043</ArticleId><ArticleId IdType="pmc">PMC6520659</ArticleId><ArticleId IdType="pubmed">31143184</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K., Thammisetty S.S., Boutej H., Bareil C., Julien J.-P. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling. J. Neurosci. 2020;40:5137&#x2013;5154. doi: 10.1523/JNEUROSCI.0536-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0536-20.2020</ArticleId><ArticleId IdType="pmc">PMC7314413</ArticleId><ArticleId IdType="pubmed">32457070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyrargyri V., Vega-Flores G., Gruart A., Delgado-Garc&#xed;a J.M., Probert L. Differential Contributions of Microglial and Neuronal IKK&#x3b2; to Synaptic Plasticity and Associative Learning in Alert Behaving Mice. Glia. 2015;63:549&#x2013;566. doi: 10.1002/glia.22756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22756</ArticleId><ArticleId IdType="pubmed">25297800</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of Widespread Cerebral Microglial Activation in Amyotrophic Lateral Sclerosis: An [11C](R)-PK11195 Positron Emission Tomography Study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Geloso M.C., Corvino V., Marchese E., Serrano A., Michetti F., D&#x2019;Ambrosi N. The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches. Front. Aging Neurosci. 2017;9 doi: 10.3389/fnagi.2017.00242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00242</ArticleId><ArticleId IdType="pmc">PMC5524666</ArticleId><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Crain J.M., Nikodemova M., Watters J.J. Microglia Express Distinct M1 and M2 Phenotypic Markers in the Postnatal and Adult Central Nervous System in Male and Female Mice. J. Neurosci. Res. 2013;91:1143&#x2013;1151. doi: 10.1002/jnr.23242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23242</ArticleId><ArticleId IdType="pmc">PMC3715560</ArticleId><ArticleId IdType="pubmed">23686747</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S.H., Zhao W., Beers D.R., Henkel J.S. The Microglial-Motoneuron Dialogue in ALS. Acta Myol. 2011;30:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3185827</ArticleId><ArticleId IdType="pubmed">21842586</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Zhao W., Appel S.H. Microglia in ALS: The Good, The Bad, and The Resting. J. Neuroimmune Pharmacol. 2009;4:389&#x2013;398. doi: 10.1007/s11481-009-9171-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId><ArticleId IdType="pubmed">19731042</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Reichel J.M., Han C., Zuniga-Hertz J.P., Cai D. Astrocytic Process Plasticity and IKK&#x3b2;/NF-&#x39a;B in Central Control of Blood Glucose, Blood Pressure, and Body Weight. Cell Metab. 2017;25:1091&#x2013;1102.e4. doi: 10.1016/j.cmet.2017.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.04.002</ArticleId><ArticleId IdType="pmc">PMC5576872</ArticleId><ArticleId IdType="pubmed">28467927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh M., Yang Y., Rothstein J.D., Robinson M.B. Nuclear Factor-&#x39a;B Contributes to Neuron-Dependent Induction of Glutamate Transporter-1 Expression in Astrocytes. J. Neurosci. 2011;31:9159&#x2013;9169. doi: 10.1523/JNEUROSCI.0302-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0302-11.2011</ArticleId><ArticleId IdType="pmc">PMC3138498</ArticleId><ArticleId IdType="pubmed">21697367</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannoni F., Quintana F.J. The Role of Astrocytes in CNS Inflammation. Trends Immunol. 2020;41:805&#x2013;819. doi: 10.1016/j.it.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.07.007</ArticleId><ArticleId IdType="pubmed">32800705</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Barres B.A. Reactive Astrocytes: Production, Function, and Therapeutic Potential. Immunity. 2017;46:957&#x2013;967. doi: 10.1016/j.immuni.2017.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.06.006</ArticleId><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.-S., Peterson T.C., et al. Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N., Schurr C., Olde Heuvel F., Tang L., Li Q., Tasdogan A., Kimbara A., Nettekoven M., Ottaviani G., Raposo C., et al. NF-&#x3ba;B Activation in Astrocytes Drives a Stage-specific Beneficial Neuroimmunological Response in ALS. EMBO J. 2018;37 doi: 10.15252/embj.201798697.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798697</ArticleId><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as Determinants of Disease Progression in Inherited ALS. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>